Deployment of a Biomedical Research Laboratory for Suborbital Spaceflight: the Experience from the Virtute-1 Mission

Suborbital spaceflight platforms are increasingly being considered as accessible environments for conducting life-science research under spaceflight conditions. Biological investigations during space missions play an important role in improving our understanding of the physiological, cellular, and molecular responses elicited by spaceflight-related stressors, thereby contributing to the scientific knowledge required to support astronaut health and the development of future space exploration programs. As access to suborbital platforms expands, appropriate laboratory facilities are needed to collect, preserve, and process biological samples within the constraints imposed by flight operations. This note describes the planning, deployment, and operations of a temporary biomedical laboratory established at Spaceport America in support of the Virtute-1 mission, conducted during Virgin Galactic’s Galactic-01 research flight. The laboratory was designed to support biomedical activities involving both human participants and cellular payloads, including pre- and post-flight biological sample collection, cell-culture management, cold-chain preservation, and logistics associated with the transport of biological materials and scientific equipment. The laboratory was integrated within the flight environment of the Gateway to Space facility and required coordination of aerospace, biomedical, clinical, regulatory, and logistical stakeholders from public and private institutions. Particular attention was dedicated to biosafety procedures, infrastructure adaptation, equipment deployment, transportation planning, and mission-driven workflow integration. This paper describes how these activities were organized and implemented during a commercial suborbital mission. The experience gained during Virtute-1 provides practical considerations for the deployment of biomedical laboratories at commercial spaceports and for future life-science investigations using suborbital platforms.

Authors

Institutions

Publication Details

Journal
Microgravity Science and Technology
Published
2026-10-03
DOI
https://doi.org/10.1007/s12217-026-10290-z
Primary Topic
Spaceflight effects on biology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Deployment of a Biomedical Research Laboratory for Suborbital Spaceflight: the Experience from the Virtute-1 Mission

Leonardo Catamo, Marco Lastilla, Simona Ferraro, Laura Riboni et al.
Microgravity Science and Technology
Spaceflight effects on biology
article

Deployment of a Biomedical Research Laboratory for Suborbital Spaceflight: the Experience from the Virtute-1 Mission

Leonardo Catamo, Marco Lastilla, Simona Ferraro, Laura Riboni, Laura Guarnaccia, Pietro Tondo, Marco Locatelli, Pietro Perelli, Emanuele Garzia, Giuseppe Ciniglio Appiani, Giovanni Marfia, Noreen M. Gervasi, Gianvincenzo Zuccotti, Stefania Elena Navone, Angelo Landolfi, Laura Begani, Emanuela Barilla, Giovanni Andrea Alotta, Monica Miozzo, Laura Fontana, Efrem Moioli
article en

Abstract

Suborbital spaceflight platforms are increasingly being considered as accessible environments for conducting life-science research under spaceflight conditions. Biological investigations during space missions play an important role in improving our understanding of the physiological, cellular, and molecular responses elicited by spaceflight-related stressors, thereby contributing to the scientific knowledge required to support astronaut health and the development of future space exploration programs. As access to suborbital platforms expands, appropriate laboratory facilities are needed to collect, preserve, and process biological samples within the constraints imposed by flight operations. This note describes the planning, deployment, and operations of a temporary biomedical laboratory established at Spaceport America in support of the Virtute-1 mission, conducted during Virgin Galactic’s Galactic-01 research flight. The laboratory was designed to support biomedical activities involving both human participants and cellular payloads, including pre- and post-flight biological sample collection, cell-culture management, cold-chain preservation, and logistics associated with the transport of biological materials and scientific equipment. The laboratory was integrated within the flight environment of the Gateway to Space facility and required coordination of aerospace, biomedical, clinical, regulatory, and logistical stakeholders from public and private institutions. Particular attention was dedicated to biosafety procedures, infrastructure adaptation, equipment deployment, transportation planning, and mission-driven workflow integration. This paper describes how these activities were organized and implemented during a commercial suborbital mission. The experience gained during Virtute-1 provides practical considerations for the deployment of biomedical laboratories at commercial spaceports and for future life-science investigations using suborbital platforms.

Microgravity Science and TechnologyVol. 38(5)
AOL (United States) (US), University of Milan (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Italian Association for Cancer Research (IT), Ospedale dei Bambini Vittore Buzzi (IT), Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo, Aeronautica Militare (IT), Andremacon Srl (Italy) (IT)
Openalex Percentile: Top 12%
Spaceflight effects on biology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.